Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Head-to-head Comparison of the Two Commercially Available Approved TIGRA (QuantiFERON-TB Gold In-Tube and T.SPOT.TB) With the Established Mendel-Mantoux Skin-test in Immunocompromized Patients

NCT00707317 is registered in ClinicalTrials.gov with Tuberculosis Network European Trialsgroup as lead sponsor.

NCT NCT00707317
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00707317 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Head-to-head Comparison of the Two Commercially Available Approved TIGRA (QuantiFERON-TB Gold In-Tube and T.SPOT.TB) With the Established Mendel-Mantoux Skin-test in Immunocompromized Patients
Lead sponsor
Tuberculosis Network European Trialsgroup
Phase
Observational
Overall status
Completed
Start date
June 30, 2008
Completion date
May 31, 2011
Enrollment
1,843 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

monitoring, immunologic, tuberculosis